Sure, no doubt. Genomic surveillance of edited cell lines is going to become cheap, granular and pervasive. Good thing, too, as Bradley et Al.(among others) have demonstrated that existing techniques are prone to generating problems which can go undetected by older, gross-scale surveillance.